A team of scientists has developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumour efficacy, as ...

Drug delivery systems often face two critical ... Given the vast range of possible interactions in peptide design, it may be feasible to tailor peptides for specific drugs, extending their ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has today announced additional in vivo validation for its first-in-class approach against cancer as the Company continues to apply its ...